OTC

Strength

325; 10; 200; 5 mg/15mL; mg/15mL; mg/15mL; mg/15mL

Manufacturer

L. Perrigo Company

NDC

00113060334

Classification

Generic

Dosage Form

SOLUTION

Route

ORAL

Last Updated

5/19/2021

Approval Type

OTC MONOGRAPH DRUG

FDA Application

M012

On Market Since

11/19/2013

Pharmacological Classes

Adrenergic alpha1-Agonists
Decreased Respiratory Secretion Viscosity
Expectorant
Increased Respiratory Secretions
Sigma-1 Agonist
Sigma-1 Receptor Agonists
Uncompetitive N-methyl-D-aspartate Receptor Antagonist
Uncompetitive NMDA Receptor Antagonists
alpha-1 Adrenergic Agonist

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

+0.4%

All

+13.7%